Biovista announces strong preclinical results for two drugs targeting Niemann-Pick Disease Type A

January 12, 2017Press Releases

CHARLOTTESVILLE, Va. – Jan. 12, 2017 – Biovista Inc. today announced that two drugs targeting Niemann-Pick Disease Type A (NPA), have shown strong positive results in the Acid Sphingomyelinase ASM knock-out (ASMKO) mouse model. Both repositioning candidates (BVA-901A and BVA-901B) tested by the laboratory of Dr. M.D. Ledesma at the Madrid Center for Molecular Biology … Read More

Vizit, a tool for biomedical link-based browsing

November 29, 2016Vizit Blog

There’s keyword-based search, there is suggestions and then there is link-based browsing. Keyword-based search is what we all do when we enter words in databases and search sites such as Google and Bing. Suggestions is related “stuff” the computer presents us with when we search YouTube, Amazon, iTunes and other such sites. Link-based browsing differs … Read More

Vizit: a visual bibliographic search tool based on PubMed

November 10, 2016Vizit Blog

Vizit is a powerful new way to search the scientific bibliography and a great complement to PubMed. Through its graphical interface, Vizit helps scientists get a quick overview of a research area, discover non-obvious biologically relevant interactions and drill down to the published literature to read on the details. It also supports sharing and collaboration … Read More

Biotrend Chemikalien GmbH awards contract to Biovista Inc. for its Vizit literature search tool

November 3, 2016Press Releases, Vizit Blog

Charlottesville, VA, November 3rd, 2016 — Biovista Inc. today announced the signing of a contract with Biotrend Chemikalien GmbH1 for access to Biovista’s2 Vizit3 visual search engine. Biotrend will be offering Vizit as a free resource to visitors of its web site. Vizit is a visual search engine of PubMed articles that allows researchers and … Read More

Vizit usage example series: Cancer immunotherapy

October 26, 2016Vizit Blog

The purpose of this post is to demonstrate the utility of Biovista’s Vizit to review and explore specific biomedical domains. In the current example, Vizit is used to identify genes, cell types and microbiome organisms related to Regulatory T cells (Tregs) in the setting of cancer immunotherapy. These entities may have an impact on the … Read More